Bortezomib, 500 mg

Bortezumib is offered in laboratory-suitable formats for research and production. It is a peptide aldehyde with a molecular formula of C38H49N11O10S and a molecular weight of 818.8 g/mol. This compound belongs to the class of proteasome inhibitors. Bortezumib is available in a high-purity format, suitable for sensitive assays and experiments. Its unique structure allows it to selectively inhibit the chymotrypsin-like activity of the 20S proteasome, making it an essential tool in cancer research and treatment. Additionally, bortezumib has been shown to exhibit potent antiproliferative effects against various types of cancer cells, including multiple myeloma and mantle cell lymphoma.

• CAS Number: 179324-69-7